Comparative Effectiveness Research
Volume 5, 2015 - Issue
Open access
65
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents
Nicole Meyer1 Truven Health Analytics, Cambridge, MA, USACorrespondence[email protected]
, Yanni Hao2 Novartis Pharmaceuticals, East Hanover, NJ, USA
, Pamela Landsman-Blumberg1 Truven Health Analytics, Cambridge, MA, USA
, William Johnson1 Truven Health Analytics, Cambridge, MA, USA
, Paul Juneau3 Truven Health Analytics, Washington, DC, USA
& Jaqueline Willemann Rogerio2 Novartis Pharmaceuticals, East Hanover, NJ, USA
Pages 21-34
|
Published online: 28 Apr 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.